MedCity Information June 13, 2021
Lately, numerous area of interest distributors have entered the market, promising important financial savings for payers in the event that they “carve-out” specialty pharmacy companies from built-in pharmacy advantages administration (PBM). Whereas the financial savings they declare to supply sound undeniably enticing, they’re typically significantly exaggerated.
Specialty drugs – high-cost drugs that deal with advanced, persistent situations – have turn into a key driver of total prescription drug spend. Actually, in keeping with CVS Well being’s 2020 Drug Pattern Report, they account for 52% of spend regardless of being utilized by solely 2.5% of all sufferers. Spending on these drugs is rising quickly as extra specialty therapies proceed to be launched at excessive costs and drugs already out there receive supplemental indications to deal with extra…